Syngene International
SYNGENE
Pharma₹359.05
price as of 3/10/2026, 12:13:03 am
Market cap ₹14,452 Cr
- P/E
- 66.25
- Day range
- ₹353.30 – ₹365.30
- 52-week range
- ₹353.30 – ₹678.95
- Volume
- 5.30 L
- Open
- ₹365.30
- Prev close
- ₹365.30
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
SYNGENE in NSE indices and F&O
Research profile
Derived metrics
- Earn. yield
- 1.5%
Appears in 1 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 44 in Pharma| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Sun PharmaSUNPHARMA | ₹432.1K Cr | 35.71 | 5.18 | 14.8% | 21.0% | 29.0% | 0.06 | +10.5% |
| Divi's LaboratoriesDIVISLAB | ₹245.5K Cr | 83.82 | 14.66 | 16.2% | 22.0% | 41.0% | 0.00 | +27.8% |
| Torrent PharmaTORNTPHARM | ₹181.3K Cr | 76.11 | 19.22 | 26.8% | 15.0% | 34.0% | 1.79 | +54.8% |
| Apollo HospitalsAPOLLOHOSP | ₹116.9K Cr | 56.14 | 13.60 | 22.6% | 17.0% | 16.0% | 0.90 | +20.6% |
| Zydus LifesciencesZYDUSLIFE | ₹114.3K Cr | 25.57 | 4.26 | 20.1% | 21.0% | 24.0% | 0.46 | +22.0% |
| CiplaCIPLA | ₹108.6K Cr | 32.26 | 3.20 | 11.8% | 15.0% | 17.0% | 0.02 | +2.3% |
| Laurus LabsLAURUSLABS | ₹107.2K Cr | 98.02 | 20.20 | 18.2% | 18.0% | 32.0% | 0.48 | +29.0% |
| Syngene InternationalSYNGENE | ₹14.5K Cr | 66.25 | — | — | — | — | — | — |
| Sector median | ₹45.8K Cr | 49.95 | 5.80 | 14.6% | 16.0% | 22.5% | 0.31 | +17.1% |
Sector as classified in the tracked universe; medians use every tracked Pharma company, and P/E only profitable ones. Tinted figures beat the median.
Financials not yet synced
This company is tracked, but its filings have not been processed yet. Results appear here once the next sync reaches it.
Corporate actions
No dividends, splits or bonuses recorded for this company yet.
FAQ
Syngene International: common questions
Answered from the figures on this page.
Syngene International last traded at ₹359.05 (NSE, as of 3 Oct 2026). The last session moved it down 1.71%.
Syngene International is valued at about ₹14,452 crore (NSE, as of 3 Oct 2026).
Syngene International trades at a price-to-earnings ratio of 66.25 (NSE, as of 3 Oct 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.
Syngene International has traded between ₹353.30 and ₹678.95 over the past 52 weeks, to 3 Oct 2026. It is currently 2% of the way up that range.
Syngene International (SYNGENE) is classified under Pharma on this site's screener.
